Lori Kunselman

An MTP Inhibitor That Normalizes Atherogenic Lipoprotein Levels in WHHL Rabbits

John R. Wetterau, Richard E. Gregg, Thomas Harrity et al. · Science · 1998 · 268 citations

Hyperlipidemia, Whhl Rabbits, Metabolic Syndrome +17

Amphotericin B lipid complex therapy of experimental fungal infections in mice

Junius M. Clark, R R Whitney, Steven Olsen et al. · Antimicrobial Agents and Chemotherapy · 1991 · 159 citations · Full text

Antifungal Agent, Health Sciences, Antifungal Agents +11

Lipophilic 1,1-bisphosphonates are potent squalene synthase inhibitors and orally active cholesterol lowering agents in vivo.

Carl P. Ciosek, David R. Magnin, Thomas Harrity et al. · Journal of Biological Chemistry · 1993 · 102 citations · Full text

Pharmaceutical Science, Lipophilic 1,1-Bisphosphonates, Pharmacotherapy +16

Muraglitazar, a Novel Dual (α/γ) Peroxisome Proliferator–Activated Receptor Activator, Improves Diabetes and Other Metabolic Abnormalities and Preserves β-Cell Function in <i>db/db</i> Mice

Thomas Harrity, Dennis Farrelly, Aaron Tieman et al. · Diabetes · 2006 · 80 citations · Full text

Ppar Target Genes, Immunology, Pharmacotherapy +19

A Novel Series of Highly Potent Benzimidazole-Based Microsomal Triglyceride Transfer Protein Inhibitors

Jeffrey A. Robl, Richard Sulsky, Chong‐Qing Sun et al. · Journal of Medicinal Chemistry · 2001 · 61 citations · Full text

Medicinal Chemistry, Pharmaceutical Chemistry, Novel Series +13